FrancophonIA/ELRC3.0 huggingface dataset:
English: For treatment of relapsed or refractory B-precursor ALL, the dose depends on the patient's bodyweight.
Latvian: Recidivējošas vai rezistentas B prekursora ALL ārstēšanai deva ir atkarīga no pacienta ķermeņa masas.
English: Each cycle of treatment is separated by a 2-week treatment-free interval.
Latvian: Katram ārstēšanas ciklam seko 2 nedēļu pārtraukums bez ārstēšanas.
English: A study in 70 children aged 1 year and above with Philadelphia-chromosome-negative B-precursor ALL found that in 33% of patients treatment with Blincyto led to a resolution of the disease.
Latvian: Pētījumā ar 70 bērniem no 1 gada vecuma, kuriem bija Filadelfijas hromosomas negatīva B prekursora ALL, konstatēja, ka 33 % ar Blincyto ārstēto pacientu slimība izzuda.
English: How does Blincyto work?
Latvian: Kā Blincyto darbojas?
English: The active substance in Blincyto, blinatumomab, is an antibody that has been designed to attach to a protein (CD19) found on B cells, including ALL cells.
Latvian: Blincyto aktīvā viela blinatumomabs ir antiviela, kas izstrādāta, lai piesaistītos B šūnās, tostarp ALL šūnās, esošajai olbaltumvielai (CD19).
English: Blincyto is a medicine used to treat a blood cancer called B-precursor acute lymphoblastic leukaemia (ALL) in patients above 1 year of age when the cancer has come back (relapsed) or has not improved with previous treatment (refractory).
Latvian: Blincyto ir zāles, ko lieto, lai ārstētu asins vēzi, ko dēvē par B prekursora akūtu limfoblastisku leikozi (ALL), pacientiem no 1 gada vecuma, kuriem vēzis ir atgriezies (recidivējis) vai nav mazinājies pēc iepriekšējas ārstēšanas (rezistents).
English: For treatment of patients with minimal residual disease, the dose depends on the patient's bodyweight.
Latvian: Minimālas atlikušās slimības gadījumā deva ir atkarīga no pacienta ķermeņa masas.
English: Blincyto is also effective at removing residual cancer cells in adults who have been treated for B-precursor ALL and who are at high risk of the cancer coming back.
Latvian: Blincyto arī efektīvi likvidē atlikušās vēža šūnas pieaugušajiem, kuriem ir ārstēta B prekursora ALL un kuriem pastāv augsts vēža recidīva risks.
English: What are the risks associated with Blincyto?
Latvian: Kāds risks pastāv, lietojot Blincyto?
English: Patients may be treated for up to 3 additional treatment cycles, each one given after a 2-week treatment-free interval.
Latvian: Pacientiem var tikt veikti 3 papildu ārstēšanas cikli, starp kuriem ir 2 nedēļu ilgs pārtraukums bez ārstēšanas.
English: Blincyto has been studied in one main study in 189 Philadelphia-chromosome-negative adults with Bprecursor ALL whose leukaemia had come back or had not improved with treatment.
Latvian: Blincyto tika pētītas vienā pamatpētījumā, iesaistot 189 pacientus ar Filadelfijas hromosomas negatīvu B prekursora ALL, kuriem leikēmija bija recidivējusi vai pēc ārstēšanas nebija mazinājusies.
English: Blincyto is given by infusion (drip) into a vein using a pump device.
Latvian: Blincyto ievada infūzijas veidā vēnā (pa pilienam), izmantojot infūzijas sūkni.
English: How is Blincyto used?
Latvian: Kā lieto Blincyto?
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Blincyto have also been included in the summary of product characteristics and the package leaflet.
Latvian: Turklāt zāļu aprakstā un lietošanas instrukcijā tika ietverti ieteikumi un piesardzības pasākumi, kas jāievēro veselības aprūpes speciālistiem un pacientiem, lai garantētu drošu un efektīvu Blincyto lietošanu.
English: For the full list of side effects of Blincyto, see the package leaflet.
Latvian: Pilnu visu ziņoto blakusparādību sarakstu, lietojot Blincyto, skatīt zāļu lietošanas instrukcijā.
English: Sweden Medical Valley Invest AB
Latvian: Medical Valley Invest AB
English: Pregabalina Merck
Latvian: Pregabalina Merck pregabalīns
English: Active Substance
Latvian: Aktīvā viela
English: Teva Nederland B.V.
Latvian: Nīderlande Teva Nederland B.V.
English: Annex I List of nationally authorised medicinal products and marketing authorisation applications
Latvian: Valsts reģistrēto zāļu un reģistrācijas apliecību pieteikumu saraksts
English: Bristol Laboratories Limited
Latvian: Lielbritānija Bristol Laboratories Limited
English: Brown & Burk UK Limited
Latvian: Lielbritānija Brown & Burk UK Limited
English: Annex IA: Medicinal products recommended for maintenance and marketing authorisation applications for which bioequivalence vis-à-vis the EU reference medicinal product has been established
Latvian: Zāles, ko iesaka uzturošai terapijai un reģistrācijas apliecību pieteikumi, kuriem noteikta bioekvivalence ar ES atsauces zālēm
English: Medipha Sante AMOXICILLINE MEDIPHA 1 g amoxicillin
Latvian: Medipha Sante AMOXICILLINE MEDIPHA 1 g amoksicilīns
English: Iceland Lyfis ehf.
Latvian: Lyfis ehf.
English: Malacomp HEXAL junior atovaquone/ proguanil
Latvian: Malacomp HEXAL junior atovakvons/ proguanils
English: amoxicillin mg
Latvian: amoksicilīns mg
English: Eprosartan Hetero eprosartan
Latvian: Eprosartan Hetero eprosartāns
English: EBASTINE BIOGARAN ebastine
Latvian: EBASTINE BIOGARAN ebastīns
English: Rasagiline Brown & Burk 1mg Tablets rasagiline
Latvian: Rasagiline Brown & Burk 1mg Tablets rasagilīns
English: Annex IB: Products for which the marketing authorisations are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation
Latvian: Zāles, kurām ieteikts apturēt reģistrācijas apliecību darbību, un reģistrācijas apliecību pieteikumi, kuri neatbilst reģistrācijas apliecības piešķiršanas kritērijiem
English: Active Substance Strength Pharmaceutical Form
Latvian: Stiprums Zāļu forma Lietošanas veids
English: Teva UK Limited
Latvian: Lielbritānija Teva UK Limited
English: Erlotinib Ratiopharm erlotinib
Latvian: Erlotinib Ratiopharm erlotinibs
English: Germany Hormosan Pharma
Latvian: Hormosan Pharma
English: EBASTINE ZENTIVA ebastine
Latvian: EBASTINE ZENTIVA ebastīns
English: Genepharm SA ERLOTINIB/GENEPHARM erlotinib
Latvian: Genepharm SA ERLOTINIB/GENEPHARM erlotinibs
English: Sandoz Limited
Latvian: Lielbritānija Sandoz Limited
English: Tramadol/Paracétamol Zydus France tramadol/ paracetamol
Latvian: Tramadol/Paracétamol Zydus France tramadols/ paracetamols
English: Finland Sandoz A/S
Latvian: Sandoz A/S
English: eprosartan
Latvian: eprosartāns
English: Saquinavir Accord 500 mg plėvele dengtos tabletės saquinavir
Latvian: Saquinavir Accord 500 mg plėvele dengtos tabletės sahinavīrs
English: Amoxicilina Brown amoxicillin
Latvian: Amoxicilina Brown amoksicilīns
English: Tramadol/Paracétamol Nialex tramadol/ paracetamol
Latvian: Tramadol/Paracétamol Nialex tramadols/ paracetamols
English: tramadol/ paracetamol
Latvian: tramadols/ paracetamols
English: Celecoxib Medical Valley celecoxib
Latvian: Celecoxib Medical Valley celekoksibs
English: Rasagilin Micro Labs 1 mg Tabletten rasagiline
Latvian: Rasagilin Micro Labs 1 mg Tabletten rasagilīns
English: Pregabalina Lupin pregabalin
Latvian: Pregabalina Lupin pregabalīns
English: Saquinavir Accord saquinavir
Latvian: Saquinavir Accord sahinavīrs
English: Celecoxib Brill Pharma 100 mg and 200 mg cápsulas duras celecoxib
Latvian: Celecoxib Brill Pharma 100 mg and 200 mg cápsulas duras celekoksibs
English: Amoxicilline Authou amoxicillin
Latvian: Amoxicilline Authou amoksicilīns
English: EBASTINE MYLAN ebastine
Latvian: EBASTINE MYLAN ebastīns
English: Celecoxib Hetero celecoxib
Latvian: Celecoxib Hetero celekoksibs
English: Erlotinib Teva Pharma erlotinib
Latvian: Erlotinib Teva Pharma erlotinibs
English: Erlotinib Teva Generics erlotinib
Latvian: Erlotinib Teva Generics erlotinibs
English: Pregabalin Lupin 25mg hard capsules pregabalin
Latvian: Pregabalin Lupin 25mg hard capsules pregabalīns
English: ERLOTINIB SANDOZ erlotinib
Latvian: ERLOTINIB SANDOZ erlotinibs
English: Erlotinib Zidrium erlotinib
Latvian: Erlotinib Zidrium erlotinibs
English: Pregabalin Merck 25 mg kemény kapszula pregabalin
Latvian: Pregabalin Merck 25 mg kemény kapszula pregabalīns
English: Erlotinib Vipharm erlotinib
Latvian: Erlotinib Vipharm erlotinibs
English: Erlotinib PharmaSwiss erlotinib
Latvian: Erlotinib PharmaSwiss erlotinibs
English: Pharmaceutica l Form
Latvian: Zāļu forma Lietošanas veids
English: 10 mg Orodispersible tablet
Latvian: 10 mg Mutē disperģējamā tablete
English: Eprosartan Aristo 600 mg Filmtabletten eprosartan
Latvian: Eprosartan Aristo 600 mg Filmtabletten eprosartāns
English: ebastine
Latvian: ebastīns
English: Amoxicillin Micro Labs 1000 mg amoxicillin
Latvian: Amoxicillin Micro Labs 1000 mg amoksicilīns
English: Saquinavir Accord 500 mg film-coated tablets saquinavir
Latvian: Saquinavir Accord 500 mg film-coated tablets sahinavīrs
English: Saquinavir saquinavir
Latvian: Saquinavir sahinavīrs
English: SAQUINAVIR SANDOZ saquinavir
Latvian: Saquinavir Sandoz sahinavīrs
English: Saquinavir Sandoz saquinavir
Latvian: SAQUINAVIR SANDOZ sahinavīrs
English: Germany Glenmark Arzneimittel
Latvian: Glenmark Arzneimittel GmbH
English: Denmark ratiopharm GmBH
Latvian: Dānija ratiopharm GmBH
English: Amoxicillin Micro Labs 750 mg amoxicillin
Latvian: Amoxicillin Micro Labs 750 mg amoksicilīns
English: 25 mg Capsule, hard Oral use
Latvian: 25 mg Kapsula, cietā Iekšķīgai lietošanai
English: Erlotinib Sandoz 25 mg erlotinib
Latvian: Erlotinib Sandoz 25 mg erlotinibs
English: Celecoxib
Latvian: celekoksibs
English: Pregabalin-Hormosan 25 mg Hartkapseln pregabalin
Latvian: Pregabalin-Hormosan 25 mg Hartkapseln pregabalīns
English: Erlotinib Sandoz 100 mg erlotinib
Latvian: Erlotinib Sandoz 100 mg erlotinibs
English: 20 mg Capsule
Latvian: 20 mg Kapsula
English: Amoxicillin Micro Labs 250 mg amoxicillin
Latvian: Amoxicillin Micro Labs 250 mg amoksicilīns
English: Hydrochlorothiazide Micro Labs 150 mg/12.5 mg Filmtabletten irbesartan/ hydrochlorothiazide
Latvian: Hydrochlorothiazide Micro Labs 150 mg/12.5 mg Filmtabletten irbesartāns/ hidrohlortiazīds
English: 60 mg Capsule
Latvian: 60 mg Kapsula
English: 30 mg Capsule
Latvian: 30 mg Kapsula
English: Erlotinib Sandoz 150 mg erlotinib
Latvian: Erlotinib Sandoz 150 mg erlotinibs
English: Finland ratiopharm GmbH
Latvian: Somija ratiopharm GmbH
English: Amoxicillin Micro Labs 500 mg amoxicillin
Latvian: Amoxicillin Micro Labs 500 mg amoksicilīns
English: Abacavir / Lamivudine abacavir/ lamivudine
Latvian: Abacavir / Lamivudine abakavīrs/ lamivudīns
English: Etoricoxib PhaRes 120 mg Filmtabletten etoricoxib
Latvian: Etoricoxib PhaRes 120 mg Filmtabletten etorikoksibs
English: Hydrochlorothiazide Micro Labs 300 mg/12.5 mg Filmtabletten irbesartan/ hydrochlorothiazide
Latvian: Hydrochlorothiazide Micro Labs 300 mg/12.5 mg Filmtabletten irbesartāns/ hidrohlortiazīds
English: Celecoxib Glenmark 100 mg Hartkapseln celecoxib
Latvian: Celecoxib Glenmark 100 mg Hartkapseln celekoksibs
English: Celecoxib Glenmark 200 mg Hartkapseln celecoxib
Latvian: Celecoxib Glenmark 200 mg Hartkapseln celekoksibs
English: Celecoxib axcount 100 mg Hartkapseln celecoxib
Latvian: Celecoxib axcount 100 mg Hartkapseln celekoksibs
English: Celecoxib axcount 200 mg Hartkapseln celecoxib
Latvian: Celecoxib axcount 200 mg Hartkapseln celekoksibs
English: Eletriptan Mylan eletriptan
Latvian: Eletriptan Mylan eletriptāns
English: Irbesartan / Hydrochlorothiazide Micro Labs 300 mg /25 mg Filmtabletten irbesartan/ hydrochlorothiazide
Latvian: Irbesartan / Hydrochlorothiazide Micro Labs 300 mg /25 mg Filmtabletten irbesartāns/ hidrohlortiazīds
English: 40 mg Capsule
Latvian: 40 mg Kapsula
English: 200 mg Capsule, hard Oral use
Latvian: 200 mg Kapsula, cietā Iekšķīgai lietošanai
English: Irbesartan/Hydrochlorot hiazide Brown & Burk 150mg/12.5mg Filmcoated tablets irbesartan/ hydrochlorothiazide
Latvian: Irbesartan/Hydrochlorot hiazide Brown & Burk 150mg/12.5mg Filmcoated tablets irbesartāns/ hidrohlortiazīds
English: 20 mg Capsule, hard Oral use
Latvian: 20 mg Kapsula, cietā Iekšķīgai lietošanai
English: Irbesartan/Hydrochlorot hiazide Brown & Burk 300mg/25mg Filmcoated tablets irbesartan/ hydrochlorothiazide
Latvian: Irbesartan/Hydrochlorot hiazide Brown & Burk 300mg/25mg Filmcoated tablets irbesartāns/ hidrohlortiazīds
English: GmbH
Latvian: Ltd
English: Irbesartan/Hydrochlorot hiazide Brown & Burk 300mg/12.5mg Filmcoated tablets irbesartan/ hydrochlorothiazide
Latvian: Irbesartan/Hydrochlorot hiazide Brown & Burk 300mg/12.5mg Filmcoated tablets irbesartāns/ hidrohlortiazīds
English: Etoricoxib PhaRes 30 mg Filmtabletten etoricoxib
Latvian: Etoricoxib PhaRes 30 mg Filmtabletten etorikoksibs
English: 60 mg Capsule, hard Oral use
Latvian: 60 mg Kapsula, cietā Iekšķīgai lietošanai
English: 100 mg Capsule, hard Oral use
Latvian: 100 mg Kapsula, cietā Iekšķīgai lietošanai
English: Saquinavir Farmoz saquinavir
Latvian: Saquinavir Farmoz sahinavīrs
English: Etoricoxib PhaRes 90 mg Filmtabletten etoricoxib
Latvian: Etoricoxib PhaRes 90 mg Filmtabletten etorikoksibs
English: Duloxetin-Hormosan 20 mg magensaftresistente Hartkapseln duloxetine
Latvian: Duloxetin-Hormosan 20 mg magensaftresistente Hartkapseln duloksetīns
English: Duloxetin-Hormosan 60 mg magensaftresistente Hartkapseln duloxetine
Latvian: Duloxetin-Hormosan 60 mg magensaftresistente Hartkapseln duloksetīns
English: Etoricoxib PhaRes 60 mg Filmtabletten etoricoxib
Latvian: Etoricoxib PhaRes 60 mg Filmtabletten etorikoksibs
English: Duloxetin-Hormosan 30 mg magensaftresistente Hartkapseln duloxetine
Latvian: Duloxetin-Hormosan 30 mg magensaftresistente Hartkapseln duloksetīns
English: 30 mg Capsule, hard Oral use
Latvian: 30 mg Kapsula, cietā Iekšķīgai lietošanai
English: Duloxetin-Hormosan 40 mg magensaftresistente Hartkapseln duloxetine
Latvian: Duloxetin-Hormosan 40 mg magensaftresistente Hartkapseln duloksetīns
English: Duloxetine Lupin 30mg GR capsules duloxetine
Latvian: Duloxetine Lupin 30mg GR capsules duloksetīns
English: Duloxetine Lupin 60mg GR capsules duloxetine
Latvian: Duloxetine Lupin 60mg GR capsules duloksetīns
English: 40 mg Capsule, hard Oral use
Latvian: 40 mg Kapsula, cietā Iekšķīgai lietošanai
English: Duloxetine Lupin 40mg GR capsules duloxetine
Latvian: Duloxetine Lupin 40mg GR capsules duloksetīns
English: Duloxetine Lupin 20mg GR capsules duloxetine
Latvian: Duloxetine Lupin 20mg GR capsules duloksetīns
English: rosuvastatin
Latvian: rosuvastatīns
English: Germany Hexal Aktiengesellschaft
Latvian: Aktiengesellsch aft
English: Str. Bega Nr. 4
Latvian: Bega Nr. 4
English: List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states for all authorised methadone medicinal products for oral use containing povidone
Latvian: Zāļu nosaukumi, zāļu forma, stiprumi, lietošanas veids, un reģistrācijas apliecību īpašnieki dalībvalstīs
English: S.C. BIO EEL S.R.L.
Latvian: BIO EEL S.R.L. Str.
English: Martindale Pharmaceuticals Ltd.
Latvian: Lielbritānija Martindale Pharmaceuticals Ltd.
English: METADON BIOEEL
Latvian: METADON BIOEEL methadone
English: Metadon-EP 20 mg methadone
Latvian: Metadon-EP 20 mg tabletta
English: Metadon-EP 5 mg methadone
Latvian: Metadon-EP 5 mg tabletta
English: Depridol
Latvian: Stiprums
English: Bampton
Latvian: Bampton Road
English: Ref.: EMEA/356093/2009 EMEA/H/C/1031
Latvian: Atsauces dok.: EMEA/484298/2009 EMEA/H/C/1031
English: This prevents the cancer cells from dividing and they eventually die.
Latvian: Tādējādi tiek novērsta vēža šūnu dalīšanās, un tās galu galā iet bojā.
English: This is repeated every 21 days for six courses or until the disease gets worse.
Latvian: Šo ārstēšanas shēmu atkārto ik pēc 21 dienas, līdz veikti seši kursi vai arī kamēr slimība atsāk progresēt.
English: This means that Topotecan Actavis is similar to a ‘reference medicine' already authorised in the European Union (EU) called Hycamtin.
Latvian: Tas nozīmē, ka Topotecan Actavis ir līdzīgas „atsauces zālēm”, kas jau ir reģistrētas Eiropas Savienībā (ES) ar nosaukumu Hycamtin.
English: For lung cancer, Topotecan Actavis is given every day for five days with a three-week interval between the start of each course.
Latvian: Plaušu vēža gadījumā Topotecan Actavis indicē piecas dienas pēc kārtas ar triju nedēļu intervālu starp katra nākamā kursa sākumu.
English: When the enzyme is blocked, the DNA strands break.
Latvian: Kad ferments ir bloķēts, DNS virknes pārtrūkst.
English: Infusions should be carried out in a specialised cancer ward.
Latvian: Infūzijas drīkst veikt specializētā vēža nodaļā.
English: It is also used together with cisplatin (another anticancer medicine) to treat women with cancer of the cervix, when the cancer has come back after radiotherapy, or when the disease is at an advanced stage (stage IVB: the cancer has spread beyond the cervix).
Latvian: Tās lieto arī kopā ar cisplatīnu (citām pretvēža zālēm), lai ārstētu sievietes ar dzemdes kakla vēzi, kas recidivējis pēc radioterapijas, kā arī gadījumos, kad slimība ir progresējusi (IVB stadijā: vēzis ir izplatījies ārpus dzemdes kakla).
English: The Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Topotecan Actavis has been shown to be comparable to Hycamtin.
Latvian: Cilvēkiem paredzēto zāļu komiteja (CHMP) secināja, ka saskaņā ar ES prasībām ir pierādīta Topotecan Actavis un Hycamtin līdzvērtība.
English: The patient's blood levels of white blood cells, platelets and haemoglobin should be checked before treatment, to ensure that they are above set minimum levels.
Latvian: Pirms ārstēšanas jāpārbauda pacientes leikocītu skaits, trombocītu skaits un hemoglobīna līmenis, lai pārliecinātos, ka šie rādītāji ir virs noteiktā minimālā līmeņa.
English: Topotecan Actavis topotecan EPAR summary for the public
Latvian: Topotecan Actavis topotekāns EPAR kopsavilkums plašākai sabiedrībai
English: Treatment with Topotecan Actavis should only be given under the supervision of a doctor experienced in the use of chemotherapy.
Latvian: Ārestēšanu ar Topotecan Actavis drīkst veikt tikai tāda ārsta uzraudzībā, kam ir pieredze ķīmijterapijā.
English: It is used on its own to treat patients with small cell lung cancer, when the cancer has relapsed (come back).
Latvian: Tās lieto vienas pašas, lai ārstētu pacientes ar sīkšūnu plaušu vēzi pēc recidīva (slimības atjaunošanās).
English: The dose of Topotecan Actavis to be used depends on the type of cancer that it is being used to treat and the patient's weight and height.
Latvian: Lietojamā Topotecan Actavis deva ir atkarīga no ārstējamā vēža veida un pacientes svara un garuma.
English: The full EPAR for Topotecan Actavis can be found here.
Latvian: Pilns Topotecan Actavis EPAR teksts ir atrodams šeit.
English: Topotecan Actavis is a ‘generic medicine'.
Latvian: Topotecan Actavis ir „ģenēriskas zāles”.
English: When used with cisplatin in cervical cancer, Topotecan Actavis is given as an infusion on days 1, 2 and 3 (with cisplatin given on day 1).
Latvian: Kombinācijā ar cisplatīnu dzemdes kakla vēža terapijai Topotecan Actavis ievada infūzijas veidā 1., 2. un 3. dienā (cisplatīnu ievada 1. dienā).
English: Because Topotecan Actavis is a generic medicine, the company has provided data from the published literature on topotecan.
Latvian: Tā kā Topotecan Actavis ir ģenēriskas zāles, uzņēmums iesniedza publikāciju datus par topotekānu.
English: The Committee recommended that Topotecan Actavis be given marketing authorisation.
Latvian: Komiteja ieteica izsniegt Topotecan Actavis reģistrācijas apliecību.
English: The European Commission granted a marketing authorisation valid throughout the EU for Topotecan Actavis to Actavis Group PTC ehf.
Latvian: Eiropas Komisija 2009. gada 24 jūlijā izsniedza Topotecan Actavis reģistrācijas apliecību, kas derīga visā Eiropas Savienībā, uzņēmumam Actavis Group PTC ehf.
English: Topotecan Actavis also affects non-cancer cells, which causes side effects.
Latvian: Topotecan Actavis ietekmē ne tikai audzēja šūnas, un tas izraisa blakusparādības.
English: Because Topotecan Actavis is a generic medicine, its benefit and risk are taken as being the same as those of the reference medicine.
Latvian: Tā kā Topotecan Actavis ir ģenēriskas zāles, tad šo zāļu ieguvumu/riska attiecību uzskata par līdzvērtīgu atsauces zāļu ieguvumu/riska attiecībai.
English: What are the benefit and risk of Topotecan Actavis?
Latvian: Kāda ir ieguvumu/riska attiecība, lietojot Topotecan Actavis?
English: Why has Topotecan Actavis been approved?
Latvian: Kāpēc Topotecan Actavis tika apstiprinātas?
English: Topotecan Actavis is a powder to be made up into a solution for infusion (drip into a vein).
Latvian: Topotecan Actavis ir pulveris, no kura gatavo šķīdumu infūzijai (ievadīšanai vēnā pa pilienam).
English: Other information about Topotecan Actavis:
Latvian: Cita informācija par Topotecan Actavis.
English: The active substance in Topotecan Actavis, topotecan, is an anticancer medicine that belongs to the group ‘topoisomerase inhibitors'.
Latvian: Topotecan Actavis aktīvā viela topotekāns ir pretvēža zāles, kas pieder topoizomerāzes inhibitoru grupai.
English: Topotecan Actavis is an anticancer medicine.
Latvian: Topotecan Actavis ir pretvēža zāles.
English: For full details, see the Summary of Product Characteristics (also part of the EPAR).
Latvian: Sīkāka informācija atrodama zāļu aprakstā, kas arī ir daļa no EPAR.
English: What is Topotecan Actavis?
Latvian: Kas ir Topotecan Actavis?
English: The doses may need to be adjusted or other medicines given to the patients, when the level of white blood cells remains particularly low.
Latvian: Ja leikocītu skaits saglabājas sevišķi zems, var būt nepieciešams pielāgot devas vai dot pacientei citas zāles.
English: No additional studies were needed as Topotecan Actavis is a generic medicine that is given by infusion and contains the same active substance as the reference medicine, Hycamtin.
Latvian: Tā kā Topotecan Actavis ir ģenēriskas zāles, ko ievada infūzijas veidā un kas satur to pašu aktīvo vielu ko Hycamtin, papildpētījumi nebija nepieciešami.
English: How is Topotecan Actavis used?
Latvian: Kā Topotecan Actavis darbojas?
English: How has Topotecan Actavis been studied?
Latvian: Kā noritēja Topotecan Actavis izpēte?
English: What is Topotecan Actavis used for?
Latvian: Kāpēc lieto Topotecan Actavis?
English: The review of HPV vaccines was initiated on 9 July 2015 by the European Commission at the request of Denmark, under Article 20 of Regulation (EC) No 726/2004.
Latvian: CPV vakcīnu vērtēšanu Eiropas Komisija uzsāka 2015. gada 9. jūlijā pēc Dānijas lūguma saskaņā ar Regulas (EK) Nr. 726/2004 20. pantu.
English: The final stage of the review procedure was the adoption by the European Commission of a legally binding decision applicable in all EU Member States on 12/01/2016.
Latvian: Vērtēšanas procedūras pēdējais solis bija visām ES dalībvalstīm juridiski saistoša lēmuma pieņemšana Eiropas Komisijā 2016/01/12.
English: • CRPS and POTS are difficult to diagnose.
Latvian: • CRPS un POTS ir grūti diagnosticēt.
English: The assessment report containing the evidence supporting the Agency's review is available on EMA's website.
Latvian: Novērtējuma ziņojums, kurā iekļauti pierādījumi, kas apliecina Aģentūras pārskata izvērtējuma rezultātus, pieejams EMA tīmekļa vietnē.
English: The CHMP's position was passed to the European Commission which endorsed it and issued a legally binding decision.
Latvian: CHMP nostāja tika pārsūtīta Eiropas Komisijai, kas to atbalstīja un izdeva galīgo juridiski saistošu lēmumu.
English: • Patients or families who have any concerns should consult their healthcare professional.
Latvian: • Pacientiem vai ģimenēm šaubu gadījumā jākonsultējas ar veselības aprūpes speciālistu.
English: Following their approval, the vaccines have been introduced in national immunisation programs in many countries.
Latvian: Vakcīnas pēc apstiprināšanas ietvertas daudzu valstu imunizācijas programmās.
English: The syndromes are recognised to occur in the general population, including adolescents, regardless of vaccination.
Latvian: Šie sindromi novēroti vispārējā iedzīvotāju populācijā, tostarp arī pusaudžiem neatkarīgi no vakcinācijas.